dc.creatorMentz, Marcia Bohrer
dc.creatorTeixeira, Carlos Graeff
dc.creatorGarrido, Cinara Tentardini
dc.date2010-06-01T04:17:57Z
dc.date2004
dc.identifier0036-4665
dc.identifierhttp://hdl.handle.net/10183/23154
dc.identifier000468874
dc.descriptionAbdominal angiostrongyliasis is a zoonotic infection produced by a metastrongylid intra-arterial nematode, Angiostrongylus costaricensis. Human accidental infection may result in abdominal lesions and treatment with anti-helminthics is contra-indicated because of potential higher morbidity with excitement or death of worms inside vessels. To evaluate the effect of mebendazole on localization of the worms, male Swiss mice, 5 week-old, were infected with 10 third stage larvae per animal. Twelve infected mice were treated with oral mebendazol, at 5 mg/kg/day, for 5 consecutive days, begining 22 days after inoculation. As control groups, 12 infected but non-treated mice and other 12 non-infected and non-treated mice were studied. The findings at necropsy were, respectively for the treated (T) and control (C) groups: 92% and 80% of the worms were inside the cecal mesenteric arterial branch; 8% and 10% were located inside the aorta. Only in the group C some worms (10%) were found inside the portal vein or splenic artery. These data indicate that treatment with mebendazole does not lead to distal or ectopic migration of A. costaricensis worms.
dc.formatapplication/pdf
dc.languageeng
dc.relationRevista do Instituto de Medicina Tropical de São Paulo = Journal of the São Paulo Institute of Tropical Medicine. São Paulo, SP. Vol. 46, n. 2 (2004), p. 73-75
dc.rightsOpen Access
dc.subjectAngiostrongylus costaricencis
dc.subjectAdult stage
dc.subjectMigration
dc.subjectMebendazole
dc.subjectParasitologia
dc.titleTreatment with mebendazole is not associated with distal migration of adult Angiostrongylus costaricensis in the murine experimental infection
dc.typeArtigo de periódico
dc.typeNacional


Este ítem pertenece a la siguiente institución